MedTrace Logo

Patient Centered Outcomes Analysis for MS Using a Mobile Application

NCT04281160 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-12-23

No results posted yet for this study

Summary

Multiple Sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) that can impact all aspects of nervous system function. Currently clinical assessments as part of the standard of care are performed in the health care providers office during regularly scheduled visits and are semi-quantitative or qualitative in nature. The goal of the BeCare Multiple Sclerosis Assessment App is to allow for patient centered, frequent, and quantitative assessments of neurologic function through a mobile App. The BeCare MS App integrates with all Android and Apple operating systems. The investigator's overall goal is to improve well-being of people with MS through accurate assessment of their neurologic function to be used by themselves as well as their health care providers. The purpose of this Clinical Trial is to validate the App based assessments versus Gold-Standard clinical assessments.

Conditions

Interventions

DEVICE

BeCare Mobile App

The BeCare App is a mobile application that will perform routine assessments of neurological function in individuals with MS and address the most relevant domains that are affected in MS: cognition, afferent visual functioning, motor functioning, fine motor functioning, coordination, gait, and endurance

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    collaborator OTHER

  • BeCare Link LLC

    lead INDUSTRY

Principal Investigators

  • Larry D Rubin, MPh · Sponsor GmbH

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-19
Primary Completion
2023-09-01
Completion
2023-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04281160 on ClinicalTrials.gov